Complete patient enrollment in the VIITAL™ clinical study
Delivered after the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Jan 2021
- Due
- 31 Dec 2021
- Delivered
- Q1 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“aim to complete enrollment in 2021.”
What we found
Evidence strength A What the grades mean
The company aimed to complete enrollment in the VIITAL™ study by the end of 2021, but reported achieving target enrollment in the first quarter of 2022.
-
A Abeona Therapeutics Inc. 10-K filed 2022-03-31
“We achieved target enrollment in the first quarter of 2022.” ✓ confirmed on the page
Market reaction: the shares moved +6.9% against the S&P 500 over the three sessions around the disclosure (30 Mar 2022 to 4 Apr 2022). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- VIITAL™ study enrollment
- Language
- Aspirational (“aims”, “intends”)
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Customer
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Abeona Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ABEO-022376 · Corrections policy